<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008393.ref084">
 <label>84</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>de Vries</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Altenburg</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Nieuwkoop</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>de Bruin</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>van Trierum</surname>
   <given-names>S</given-names>
  </name>
  <etal>et al</etal>
  <article-title>Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.</article-title>
  <source>The Journal of Infectious Diseases</source>. 
  <year>2018</year>;
  <volume>218</volume>(
  <issue>4</issue>):
  <fpage>614</fpage>–
  <lpage>623</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiy214</pub-id> .
  <?supplied-pmid 29912453?>
  <pub-id pub-id-type="pmid">29912453</pub-id>
 </mixed-citation>
</ref>
